APA (7th ed.) Citation

N, B., T, R., JHM, J., C, C., K, M. E., K, K., . . . T, V. (2021). Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions. Cancer science, 112(8), 3029. https://doi.org/10.1111/cas.14999

Chicago Style (17th ed.) Citation

N, Baumann, et al. "Enhancement of Epidermal Growth Factor Receptor Antibody Tumor Immunotherapy by Glutaminyl Cyclase Inhibition to Interfere with CD47/signal Regulatory Protein Alpha Interactions." Cancer Science 112, no. 8 (2021): 3029. https://doi.org/10.1111/cas.14999.

MLA (9th ed.) Citation

N, Baumann, et al. "Enhancement of Epidermal Growth Factor Receptor Antibody Tumor Immunotherapy by Glutaminyl Cyclase Inhibition to Interfere with CD47/signal Regulatory Protein Alpha Interactions." Cancer Science, vol. 112, no. 8, 2021, p. 3029, https://doi.org/10.1111/cas.14999.